Understanding the USP and FDA Functions in the Pharmaceutical Industry 2016 is a webinar that covers topics such as:
- Absence of enforcement power for use of USP methods and regulatory status of the USP as a communication tool
- Function of the USP to share established methodology to support the growth of the generic pharmaceutical industry
- Inherent inefficiencies in the USP monograph creation process and associated liabilities created by a retrospective perspective design
- Conflicts in the charters of the USP and the FDA
- Illustrate the FDA emphasis on integrating new technology into pharmaceutical operations to improve safety and quality
Understanding the USP and FDA Functions in the Pharmaceutical Industry 2016 is intended for attendees from:
- Users in the generic pharmaceutical industry, including API manufacturers, contract laboratories and pharmaceutical manufacturers
- Generic pharmaceutical company QC Directors, QC Managers, QC Chemists, ARD Directors, ARD Managers, ARD Chemists
- Any users currently relying on the use of USP monographs without modification
